Simultaneous analytical method [Bioanalytics]

posted by Obinoscopy  – USA, 2018-09-12 07:35 (1006 d 20:34 ago) – Posting: # 19268
Views: 2,827

Dear Giang

» It's a bioanalytical method for determination of 5 anti-TB drugs by LC-MS/MS. One just raise the question: Can we apply this method for just 2/3 APIs? Is there any infuence or differences? Do we need to revalidate the method, partial or full, and which criteria? Many thanks!

I don't think you need to revalidate as long as the 2/3 APIs were among the 5 APIs that were validated.

But if I may ask, did you include all the CCs and QCs for the entire 5 APIs in the same analytical run?

Scopy

Complete thread:

Activity
 Admin contact
21,518 posts in 4,498 threads, 1,524 registered users;
online 19 (0 registered, 19 guests [including 4 identified bots]).
Forum time: Tuesday 04:09 UTC (Europe/Vienna)

I suppose it is tempting, if the only tool you have is a hammer,
to treat everything as if it were a nail.    Abraham Maslow

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5